These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3292902)

  • 21. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC Topic No. 1. Are somatic mutations involved in atherosclerosis?
    Bridges BA
    Mutat Res; 1987 Dec; 182(6):301-2. PubMed ID: 3683430
    [No Abstract]   [Full Text] [Related]  

  • 22. International Commission for Protection against Environmental Mutagens and Carcinogens. Committee 2 Final Report. Mutagenesis testing as an approach to carcinogenesis.
    Mutat Res; 1982 Jul; 99(1):73-91. PubMed ID: 6214712
    [No Abstract]   [Full Text] [Related]  

  • 23. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 2/6. An appraisal of predictive tests for carcinogenicity.
    Purchase IF
    Mutat Res; 1982 Jul; 99(1):53-17. PubMed ID: 6811893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 16. Testing for mutagens and carcinogens; the role of short-term genotoxicity assays.
    Mutat Res; 1988; 205(1-4):3-12. PubMed ID: 3285192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International Commission for Protection Against Environmental Mutagens and Carcinogens. Report of ICPEMC Subcommittee 7/1. The possible involvement of somatic mutations in the development of atherosclerotic plaques.
    Atherosclerosis; 1991 Aug; 89(2-3):255-61. PubMed ID: 1793453
    [No Abstract]   [Full Text] [Related]  

  • 26. International Commission for Protection against Environmental Mutagens and Carcinogens: ICPEMC news no. 2.
    Sobels FH
    Mutat Res; 1979 Oct; 64(5):357-61. PubMed ID: 514300
    [No Abstract]   [Full Text] [Related]  

  • 27. ICPEMC to help protect against genetic diseases and cancer.
    WHO Chron; 1978 Oct; 32(10):400-1. PubMed ID: 716383
    [No Abstract]   [Full Text] [Related]  

  • 28. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 5/6. Perspectives in mutation epidemiology, 6. A 1983 view of sentinel phenotypes.
    Mulvihill JJ; Czeizel A
    Mutat Res; 1983 Dec; 123(3):345-61. PubMed ID: 6358880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of multi-locus deletions in heterozygotes; a model study using Drosophila.
    Eeken JC; Sobels FH
    Mutat Res; 1990 Dec; 245(4):267-75. PubMed ID: 2266978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simplified method for the simultaneous detection of intragenic and intergenic mutations (deletions) in Neurospora crassa.
    Luker MA; Kilbey BJ
    Mutat Res; 1982 Feb; 92(1-2):63-8. PubMed ID: 6211615
    [No Abstract]   [Full Text] [Related]  

  • 31. Utility of Drosophila for detection of potential environmental chemical mutagens.
    Zimmering S
    Ann N Y Acad Sci; 1975 Dec; 269():26-33. PubMed ID: 817634
    [No Abstract]   [Full Text] [Related]  

  • 32. International Commission for Protection Against Environmental Mutagens and Carcinogens. The possible involvement of somatic mutations in the development of atherosclerotic plaques. Report of ICPEMC Subcommittee 7/1. Conclusions and recommendations.
    Mutat Res; 1990 Nov; 239(3):143-8. PubMed ID: 2233823
    [No Abstract]   [Full Text] [Related]  

  • 33. The mutagenic action of urethane.
    Bateman AJ
    Mutat Res; 1976; 39(1):75-96. PubMed ID: 827702
    [No Abstract]   [Full Text] [Related]  

  • 34. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 2/4: Critical assessment of the value of in vitro cell transformation for predicting in vivo carcinogenicity of chemicals.
    Brookes P
    Mutat Res; 1981 Mar; 86(2):233-42. PubMed ID: 7266571
    [No Abstract]   [Full Text] [Related]  

  • 35. International Commission for Protection Against Environmental Mutagens and Carcinogens. Genotoxicity under extreme culture conditions. A report from ICPEMC Task Group 9.
    Scott D; Galloway SM; Marshall RR; Ishidate M; Brusick D; Ashby J; Myhr BC
    Mutat Res; 1991 Mar; 257(2):147-205. PubMed ID: 2005937
    [No Abstract]   [Full Text] [Related]  

  • 36. International Commission for Protection against Environmental Mutagens and Carcinogens ICPEMC working paper 2/8: An evaluation of assay procedures for detection of tumor promotors.
    Sivak A
    Mutat Res; 1982 May; 98(3):377-87. PubMed ID: 7050698
    [No Abstract]   [Full Text] [Related]  

  • 37. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 17. Can a mechanistic rationale be provided for non-genotoxic carcinogens identified in rodent bioassays?
    Clayson DB
    Mutat Res; 1989 Jul; 221(1):53-67. PubMed ID: 2664495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 2/3: carcinogens and carcinogenesis enhancers.
    Clayson DB
    Mutat Res; 1981 Mar; 86(2):217-29. PubMed ID: 7266570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. International Commission for Protection Against Environmental Mutagens and Carcinogens. A method for combining and comparing short-term genotoxicity test data: preface. A report from ICPEMC Committee 1.
    Brusick DJ; Ashby J; de Serres FJ; Lohman PH; Matsushima T; Matter BE; Mendelsohn ML; Moore DH; Nesnow S; Waters MD
    Mutat Res; 1992 Mar; 266(1):1-6. PubMed ID: 1372961
    [No Abstract]   [Full Text] [Related]  

  • 40. The susceptibility of the fetus and child to chemical pollutants. Monitoring for human mutagenesis.
    Sutton HE
    Pediatrics; 1974 May; 53(5):800-7. PubMed ID: 4416527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.